Patents by Inventor Esben P. Friis

Esben P. Friis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11447763
    Abstract: The present invention relates to protease variants, having improved properties compared to the parent protease, in particular variants of a serine protease belonging to family 53 derived from a strain of Meripilus giganteus. The variants according to the invention have in particular increased thermo-stability, e.g., increased residual activity after 30 min at a temperature in the range from 55 to 60° C. and/or increased thermal denaturation temperature, compared to the parent Meripilus giganteus protease. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Grant
    Filed: January 14, 2021
    Date of Patent: September 20, 2022
    Assignee: NOVOZYMES A/S
    Inventors: Keiichi Ayabe, Tomoko Matsui, Aki Tomiki, Yuma Kurakata, Esben P. Friis, Jens E. Nielsen, Roland Alexander Pache
  • Patent number: 11174472
    Abstract: The present invention relates to alpha-amylase variants. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Grant
    Filed: April 24, 2020
    Date of Patent: November 16, 2021
    Assignee: Novozymes A/S
    Inventors: Carsten Andersen, Signe E. Larsen, Esben P. Friis, Peter Kamp Hansen, Henrik Friis-Madsen, Anders Viksoee-Nielsen, Pernille O. Micheelsen
  • Publication number: 20210139876
    Abstract: The present invention relates to protease variants, having improved properties compared to the parent protease, in particular variants of a serine protease belonging to family 53 derived from a strain of Meripilus giganteus. The variants according to the invention have in particular increased thermo-stability, e.g., increased residual activity after 30 min at a temperature in the range from 55 to 60° C. and/or increased thermal denaturation temperature, compared to the parent Meripilus giganteus protease. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Application
    Filed: January 14, 2021
    Publication date: May 13, 2021
    Applicant: NOVOZYMES A/S
    Inventors: Keiichi Ayabe, Tomoko Matsui, Aki Tomiki, Yuma Kurakata, Esben P. Friis, Jens E. Nielsen, Roland Alexander Pache
  • Patent number: 10927361
    Abstract: The present invention relates to protease variants, having improved properties compared to the parent protease, in particular variants of a serine protease belonging to family 53 derived from a strain of Meripilus giganteus. The variants according to the invention have in particular increased thermo-stability, e.g., increased residual activity after 30 min at a temperature in the range from 55 to 60° C. and/or increased thermal denaturation temperature, compared to the parent Meripilus giganteus protease. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Grant
    Filed: July 14, 2017
    Date of Patent: February 23, 2021
    Assignee: NOVOZYMES A/S
    Inventors: Keiichi Ayabe, Tomoko Matsui, Aki Tomiki, Yuma Kurakata, Esben P. Friis, Jens E. Nielsen, Roland Alexander Pache
  • Publication number: 20200270594
    Abstract: The present invention relates to alpha-amylase variants. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Application
    Filed: April 24, 2020
    Publication date: August 27, 2020
    Applicant: Novozymes A/S
    Inventors: Carsten Andersen, Signe E. Larsen, Esben P. Friis, Peter Kamp Hansen, Henrik Friis-Madsen, Anders Viksoee-Nielsen, Pernille O. Micheelsen
  • Publication number: 20170298302
    Abstract: The present invention relates to protease variants and methods for obtaining protease variants. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Application
    Filed: October 29, 2015
    Publication date: October 19, 2017
    Applicant: Novozymes A/S
    Inventors: Steen Krogsgaard, Rolf T. Lehnhard, Esben P. Friis
  • Patent number: 9695406
    Abstract: The present invention relates to glucoamylase variants having increased thermostability. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Grant
    Filed: March 6, 2014
    Date of Patent: July 4, 2017
    Assignee: NOVOZYMES A/S
    Inventors: Esben P. Friis, Jesper Vind, Leonardo De Maria, Bjarne G. Hansen
  • Publication number: 20160046916
    Abstract: The present invention relates to glucoamylase variants having increased thermostability. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
    Type: Application
    Filed: March 6, 2014
    Publication date: February 18, 2016
    Applicant: NOVOZYMES A/S
    Inventors: Esben P. Friis, Jesper Vind, Leonardo De Maria, Bjarne G. Hansen